The 2019 USEF Annual Meeting Registration is now open.

Medroxyprogesterone Acetate Disclosure

This form is required to be submitted if medroxyprogesterone acetate (MPA) has been administered to a horse within the 90 days preceding competition. If no additional administrations occur, one form will document compliance. However, if additional administrations take place, a new form must be filed with each administration.

If this is the first online form filed for this horse please include any administration information previously provided using the paper form.

If this is not the first online form filed for this horse please include only those administrations that have taken place since the last electronic filing.


Medication Information


To store medication information you must click ADD. You may enter multiple administrations by clicking ADD after each entry.

Competition Search



Contact Email



Identification of Horse / Pony



Doctor and Show Info